Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on January 14, 20221/14/22
A Partnership Q&A with EVERSANA and Shorla Pharma
Posted on January 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on November 4, 202111/4/21
Pharma Europe 2021 : Panel
Posted on November 2, 202111/2/21
Bio-Europe “Collaboration Close-Up”: Exploring the EVERSANA – Shorla Pharma Partnership
Posted on October 12, 202110/12/21
WEBINAR: A Pivotal Shift in Life Sciences Industry Across R&D and Commercial: A Conversation with the Experts
Posted on October 4, 202110/4/21
WEBINAR: Sustainability in Pharma: Access and Financial Returns
Posted on September 22, 20219/22/21
Getting Treatments to Patients When They Need Them Most: Next Gen Commercialization in Oncology
Posted on September 14, 20219/14/21
Simplifying EU Distribution to Maximize Cost Efficiency and Speed to Market for Patients and Manufacturers
Posted on August 31, 20218/31/21